Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

AIDS Drug Will Be Offered in Poor Countries at Cost

April 4, 2003

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Foster City, Calif.-based Gilead Sciences Inc. says it will begin offering its AIDS drug Viread at cost to 68 of the world's poorest countries. The drug maker will offer Viread to "qualified" nations throughout Africa, as well as to 15 other poor countries, for $1.30 per once-daily pill, or $475 a year. A year's supply of Viread in the United States costs roughly $4,300. Gilead said the lower price covers only its cost of manufacturing the drug and overseeing distribution. While clinics that wish to receive Viread must be accredited AIDS care facilities, they will not have to work through local governments to participate. AIDS activists called the program a welcome step but noted that, like other AIDS drug access plans in developing countries, it still falls short of the steps necessary to ensure that million of AIDS patients receive the treatment they need.

Back to other CDC news for April 4, 2003

Previous Updates

Adapted from:
Wall Street Journal
04.04.03

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More on HIV Medications
More News on Tenofovir (Viread)

Tools
 

Advertisement